Scythian Biosciences Corp. Retains The Weinberg Group To Provide FDA Consulting Services – GlobeNewswire (press release)

August 28, 2017 11:22 ET | Source: Scythian Biosciences Corp.

TORONTO, Aug. 28, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the Company) (TSXV:SCYB) is pleased to announce that it has entered into a consulting arrangement with The Weinberg Group and has retained The Weinberg Groups services for assistance with the Companys FDA application process, including pre-IND and IND consulting services.

About Scythian Biosciences Corp.

Scythian is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination.

Scythians mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen. The University of Miami believes that Scythians scientific approach shows significant promise and differs from previous approaches to treat this growing problem. The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythians clinical studies to be undertaken at their world-class facilities.

Gillian A. Hotz, PhD, is leading Scythians program at the University of Miami. Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation. She has extensive experience in neurocognitive testing. Dr. Hotz has been the co-director of University of Miami Miller School of Medicines Concussion Program since 1995.

Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.

About The Weinberg Group.

The Weinberg Group is the global leader in regulatory and compliance services, with headquarters in Washington, D.C. For over 33 years, they have provided biotech, medical device and pharmaceutical consulting services to companies of every size on every continent, supplying them with viable and efficient drug development pathways and compliance solutions.

Scythian Biosciences Corp.

Toronto, Ontario, CANADA

Scythian Biosciences Corp. Logo

LOGO URL | Copy the link below

Formats available:

Read the original post:
Scythian Biosciences Corp. Retains The Weinberg Group To Provide FDA Consulting Services - GlobeNewswire (press release)